Vanguard Group Inc Rhythm Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

  • $4.96 Trillion
  • Q1 2024

A detailed history of Vanguard Group Inc transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,304,146 shares of RYTM stock, worth $136 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,304,146
Previous 3,226,938 2.39%
Holding current value
$136 Million
Previous $148 Million 3.49%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
BUY
$39.12 - $52.44 $3.02 Million - $4.05 Million
77,208 Added 2.39%
3,304,146 $143 Million
Q4 2023

Feb 14, 2024
BUY
$21.39 - $49.64 $4.54 Million - $10.5 Million
212,370 Added 7.04%
3,226,938 $148 Million
Q3 2023

Nov 14, 2023
BUY
$15.81 - $27.8 $1.35 Million - $2.37 Million
85,139 Added 2.91%
3,014,568 $69.1 Million
Q2 2023

Aug 14, 2023
BUY
$16.32 - $21.15 $4.59 Million - $5.95 Million
281,293 Added 10.62%
2,929,429 $48.3 Million
Q1 2023

May 15, 2023
BUY
$16.88 - $34.24 $874,755 - $1.77 Million
51,822 Added 2.0%
2,648,136 $47.2 Million
Q4 2022

Feb 10, 2023
BUY
$22.25 - $30.25 $8.06 Million - $11 Million
362,042 Added 16.2%
2,596,314 $75.6 Million
Q3 2022

Nov 14, 2022
BUY
$4.3 - $30.85 $363,547 - $2.61 Million
84,546 Added 3.93%
2,234,272 $54.7 Million
Q2 2022

Aug 12, 2022
SELL
$3.12 - $12.25 $334,757 - $1.31 Million
-107,294 Reduced 4.75%
2,149,726 $8.92 Million
Q1 2022

May 13, 2022
SELL
$6.13 - $12.24 $407,651 - $813,972
-66,501 Reduced 2.86%
2,257,020 $26 Million
Q4 2021

Feb 14, 2022
BUY
$8.62 - $13.9 $90,018 - $145,157
10,443 Added 0.45%
2,323,521 $23.2 Million
Q3 2021

Nov 12, 2021
BUY
$11.68 - $20.72 $650,062 - $1.15 Million
55,656 Added 2.47%
2,313,078 $30.2 Million
Q2 2021

Aug 13, 2021
BUY
$18.52 - $22.55 $41.8 Million - $50.9 Million
2,257,422 New
2,257,422 $44.2 Million

Others Institutions Holding RYTM

# of Institutions
176
Shares Held
62.4M
Call Options Held
880K
Put Options Held
84.1K
View Full List

About RHYTHM PHARMACEUTICALS, INC.

RYTM Quotes by TradingView
  • Ticker RYTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,720,000
  • Market Cap $2.29B
  • Description
  • Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...
More about RYTM
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email